EUVIMEDEUVIMED entdecken
Crossref

Protopanaxadiol prevents cisplatin-induced acute kidney injury by regulating ferroptosis

Zeyu Song, Zhenyuan Li, Tao Pan, Teng Liu, Baifang Gong, Zhixia Wang, Ke Liu, Huaying Fan iD

Journal of Pharmacy and Pharmacology · 2024

DOI: 10.1093/jpp/rgae050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Zeyu Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Ferroptosis, Sapogenins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Acute kidney injury (AKI) caused by cisplatin (CDDP) is a complex, critical illness with no effective or specific treatment. The purpose of the study was to assess the protective effect of protopanaxadiol (PPD) on the kidneys in CDDP-induced AKI models and its possible mechanisms.

Methods

In vitro, the protection of PPD was assessed in HK-2. KM mice were injected with CDDP to induce AKI models in vivo. The determination of blood urea nitrogen and serum creatinine (SCr) was performed, and pathological changes were examined by histopathological examination. Immunostaining and western blot analyses were used to analyze the expression levels of proteins.

Results

PPD can increase the viability of HK-2 cells damaged by CDDP, improve cell morphology, and alleviate the symptoms of AKI in mice. In addition, PPD can down-regulate the protein expression of TRF and up-regulate the protein expression of Ferritin heavy chain, Glutathione peroxidase 4, and ferroptosis suppressor protein 1 reduce the iron content in cells and kidney tissues, and restore the antioxidant defense system.

Conclusion

PPD has an inhibitory effect on cisplatin-induced nephrotoxicity, which may be related to the inhibition of ferroptosis by regulating iron metabolism and lipid peroxidation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAcute Kidney InjuryFerroptosisSapogeninsAnimalsMiceHumansMaleKidneyDisease Models, AnimalCell LineLipid PeroxidationIronAntioxidantsCell Survival

Stichwörter der Autor:innen

acute kidney injurycisplatinferroptosisnephrotoxicityprotopanaxadiol

Substanzen

CisplatinprotopanaxadiolSapogeninsIronAntioxidants

Autor:innen und Institutionen

  • School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
  • Shandong Boyuan Biomedical Co., Ltd, Yantai 264003, PR China.

ORCID-Profile: Huaying Fan

Zitieren

APA

Song, Z., Li, Z., Pan, T., Liu, T., Gong, B., Wang, Z., Liu, K., & Fan, H. (2024). Protopanaxadiol prevents cisplatin-induced acute kidney injury by regulating ferroptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae050

Vancouver

Song Z, Li Z, Pan T, Liu T, Gong B, Wang Z, et al. Protopanaxadiol prevents cisplatin-induced acute kidney injury by regulating ferroptosis. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae050

BibTeX
@article{Song2024,
  author = {Song, Zeyu and Li, Zhenyuan and Pan, Tao and Liu, Teng and Gong, Baifang and Wang, Zhixia and Liu, Ke and Fan, Huaying},
  title = {Protopanaxadiol prevents cisplatin-induced acute kidney injury by regulating ferroptosis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  doi = {10.1093/jpp/rgae050}
}
Kostenlos starten →